164 related articles for article (PubMed ID: 11333473)
21. Antiphospholipid and thrombosis syndromes.
Bick RL; Baker WF
Semin Thromb Hemost; 1994; 20(1):3-15. PubMed ID: 8059232
[TBL] [Abstract][Full Text] [Related]
22. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
Mader R; Ziporen L; Mader R; Neumann L; Buskila D
Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.
Kahles T; Humpich M; Steinmetz H; Sitzer M; Lindhoff-Last E
Rheumatology (Oxford); 2005 Sep; 44(9):1161-5. PubMed ID: 15927998
[TBL] [Abstract][Full Text] [Related]
26. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
Devreese K; Hoylaerts MF
Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
[TBL] [Abstract][Full Text] [Related]
27. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
29. [Primary antiphospholipid syndrome].
Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis.
Meyer MF; Schnabel A; Schatz H; Gross WL
Semin Arthritis Rheum; 2001 Aug; 31(1):4-11. PubMed ID: 11503134
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome.
Singer HS; Krumholz A; Giuliano J; Kiessling LS
Mov Disord; 1997 Sep; 12(5):738-42. PubMed ID: 9380057
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
33. [Laboratory tests for detection of antiphospholipid antibodies].
Yasumuro Y; Taki M
Rinsho Byori; 2001 Mar; Suppl 115():91-102. PubMed ID: 11391941
[TBL] [Abstract][Full Text] [Related]
34. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
35. Clinical consequences of antiphospholipid antibodies.
Derksen RH; de Groot PG
Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
[TBL] [Abstract][Full Text] [Related]
36. Real world experience with antiphospholipid antibody tests: how stable are results over time?
Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
[TBL] [Abstract][Full Text] [Related]
37. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid antibodies and ischemic neuropathy following cardiac surgery.
Mazzoleni R; Vokaer M; Mavroudakis N; Bartholomé EJ; Bier JC
Acta Neurol Belg; 2003 Sep; 103(3):176-8. PubMed ID: 14626699
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies in children.
Manco-Johnson MJ
Semin Thromb Hemost; 1998; 24(6):591-8. PubMed ID: 10066155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
